Mepindolol
Chemical compound
- C07AA14 (WHO)
- (RS)-1-[(2-Methyl-1H-indol-4-yl)oxy]-3-(propan-2-ylamino)propan-2-ol
- 23694-81-7
- 71698
- 64750
- 00Q31ER368
- D07181
- DTXSID40865110
- Interactive image
- CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)C)O
InChI
- InChI=1S/C15H22N2O2/c1-10(2)16-8-12(18)9-19-15-6-4-5-14-13(15)7-11(3)17-14/h4-7,10,12,16-18H,8-9H2,1-3H3
- Key:NXWGWUVGUSFQJC-UHFFFAOYSA-N
Mepindolol (Betagon) is a non-selective beta blocker. It is used to treat glaucoma.[1]
See also
- Pindolol
References
- ^ Schmid MG, Gecse O, Szabo Z, Kilár F, Gübitz G, Ali I, Aboul-Enein HY (September 2001). "Comparative study of the chiral resolution of β-blockers on cellulose tris (3,5-dimethyl-phenylcarbamate) phases in normal and reversed phase modes". Journal of Liquid Chromatography & Related Technologies. 24 (16): 2493–2504. doi:10.1081/JLC-100105955.
- v
- t
- e
Beta blockers (C07)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e